Children 2-5 years of age diagnosed with atopic dermatitis (AD) prior to or at screening, may qualify to participate.  Individuals must have mild to moderate

Adults aged 18-75 years with a documented diagnosis of plaque psoriasis (disease duration of at least 6 months) are needed for this clinical research trial. 

Adults aged 18-60 years with a clinical diagnosis of alopecia areata (AA) are needed for this clinical research trial.  Eligible participants must have moderate to

Individuals from 2 to 12 years of age with a diagnosis of uncontrolled chronic spontaneous urticaria (CSU) or chronic indicuble cold urticaria (CICU) for over

Adults aged 18-75 years with a diagnosis of plaque psoriasis for 6 months or more and a weight of 40 kg (88 lbs) or more

Children, adolescents, and adults aged aged 2 years or older who have mild to moderate atopic dermatitis (AD), persistent for more than 3 months, may

Adults 18 years of age or older with a clinically confirmed diagnosis of active atopic dermatitis (AD)/eczema may qualify for this study.  Individuals must have

Individuals from 12 years of age and older diagnosed with atopic dermatitis (AD) for at least 3 months, OR plaque psoriasis (PsO) for at least

Adults aged 18 years or older with a clinical diagnosis of lichen planus (LP) with predominant cutaneous involvement are needed for this clinical research trial.

Adults aged 18 to 75 years (inclusive) with a confirmed diagnosis of active atopic dermatitis (AD) and a history of AD for at least 12

Adults at least 18 years of age who self-identify as non-white, may qualify to participate.  Must have a diagnosis of plaque psoriasis (with or without

Males and females aged 6 years and older with a clinical diagnosis of congenital ichthyosis (CI), may qualify to participate.  Must have a genetic confirmation